LeMaitre Vascular (STU:LHU) ROCE % : 14.77% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is LeMaitre Vascular ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. LeMaitre Vascular's annualized ROCE % for the quarter that ended in Mar. 2024 was 14.77%.

LeMaitre Vascular ROCE % Historical Data

The historical data trend for LeMaitre Vascular's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular ROCE % Chart

LeMaitre Vascular Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.56

13.95

15.13

10.20

12.93

LeMaitre Vascular Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															11.30	12.95	12.22	15.89	14.77

LeMaitre Vascular ROCE % Calculation

LeMaitre Vascular's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	36.199	/	( ( (293.089 - 23.911)	+	(317.995 - 27.399) )	/ 2 )
	=	36.199	/	( (269.178	+	290.596)	/ 2 )
	=	36.199	/	279.887
	=	12.93 %

LeMaitre Vascular's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	43.696	/	( ( (317.995 - 27.399)	+	(325.64 - 24.665) )	/ 2 )
	=	43.696	/	( ( 290.596	+	300.975 )	/ 2 )
	=	43.696	/	295.7855
	=	14.77 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

LeMaitre Vascular (STU:LHU) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

LeMaitre Vascular ROCE % Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

LeMaitre Vascular (STU:LHU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (STU:LHU) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

LMAT:USA LHU:Germany

Address

63 Second Avenue, Burlington, MA, USA, 01803

Website

https://www.lemaitre.com

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

LeMaitre Vascular (STU:LHU) Headlines

No Headlines